Order Article Reprints

Synowiec A, Brodaczewska K, Wcisło G, Majewska A, Borkowska A, Filipiak-Duliban A, Gawrylak A, Wilkus K, Piwocka K, Kominek A, et al. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy. International Journal of Molecular Sciences. 2023; 24(6):5715. https://doi.org/10.3390/ijms24065715

Synowiec, Agnieszka, Klaudia Brodaczewska, Gabriel Wcisło, Aleksandra Majewska, Agata Borkowska, Aleksandra Filipiak-Duliban, Aleksandra Gawrylak, Kinga Wilkus, Katarzyna Piwocka, Agata Kominek, and et al. 2023. "Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy" International Journal of Molecular Sciences 24, no. 6: 5715. https://doi.org/10.3390/ijms24065715

Synowiec, A., Brodaczewska, K., Wcisło, G., Majewska, A., Borkowska, A., Filipiak-Duliban, A., Gawrylak, A., Wilkus, K., Piwocka, K., Kominek, A., Waś, H., Lewicki, S., Siewiera, J., Szczylik, C., Szenajch, J., Kubiak, J. Z., & Kieda, C. (2023). Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy. International Journal of Molecular Sciences, 24(6), 5715. https://doi.org/10.3390/ijms24065715